Advertisement

Strahlentherapeutische Optionen nach radikaler Prostatektomie

  • T. Wiegel
  • W. Hinkelbein

Zusammenfassung

Nach der radikalen Prostatektomie, die in den USA nur in den klinischen Stadien T1-2 routinemäßig eingesetzt wird, ist postoperativ bei T1/2a-Karzinomen in bis zu 25% der Fälle ein pathologisches Stadium T3/4 nachweisbar; diese Wahrscheinlichkeit steigt bei einem klinischen T2b-c-Tumor auf über 40% [8,9]. In Deutschland werden häufig auch Patienten mit klinischen T3-Karzinomem radikal prostatektomiert. Bei diesen Stadien liegt die Wahrscheinlichkeit eines postoperativ organüberschreitenden Tumorwachstums wegen der erheblichen präoperativen Stagingunsicherheiten bei 70–80% [9,21].

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Ami Sidi A, Lange HP (1987) Adjuvant radiation therapy in patients upstaged to stage C or Di disease after radical prostatectomy. Eur Urol 13: 238–241.Google Scholar
  2. 2.
    Anscher MS (1996) Adjuvant therapy for pathologic stage C prostate cancer: a casualty of the PSA revolution? Int J Radiat Oncol Biol Phys 34: 745–747.PubMedCrossRefGoogle Scholar
  3. 3.
    Anscher MS, Prosnitz LR (1989) Radiotherapy vs. hormonal therapy for the management of locally recurrent prostate cancer following radical prostatectomy. Int J Radiat Oncol Biol Phys 17: 953–958.PubMedCrossRefGoogle Scholar
  4. 4.
    Anscher MS, Prosnitz LR (1991) Multivariate analysis of factors predicting local relapse after radical prostatectomy-possible indications for postoperative radiotherapy. Int J Radiat Oncol Biol Phys 21: 941–947.PubMedCrossRefGoogle Scholar
  5. 5.
    Anscher MS, Robertson CN, Prosnitz LR (1995) Adjuvant radiotherapy for pathologic stage T3/4 adenocarcinoma of the prostate: ten year update. Int J Radiat Oncol Biol Phys 33: 37–43.PubMedCrossRefGoogle Scholar
  6. 6.
    Cadeddu JA, Partin AW, De Weese TL, Walsh PC (1998) Long term results of radiation therapy for prostate cancer recurrence following radical prostatectomy. J Urol 159:173–178.PubMedCrossRefGoogle Scholar
  7. 7.
    Cangh PJ van, Richard F, Lorge F et al. (1998) Adjuvant radiation therapy does not cause urinary incontinence after radical prostatectomy: results of a prospective randomized study. J Urol 159: 164–166.PubMedCrossRefGoogle Scholar
  8. 8.
    Catalona WJ, Smith DS (1995) 5-year tumour recurrence rates after anatomical radical retropubic prostatectomy for prostate cancer. J Urol 152:1837–1843.Google Scholar
  9. 9.
    Cheng WS, Frydenberg M, Bergstrahl EJ, Larson-Keller JJ, Zinke H (1993) Radical prostatectomy for pathologic stage C prostate cancer: influence of pathologic variables and adjuvant treatment on disease outcome. Urology 42: 283–291.PubMedCrossRefGoogle Scholar
  10. 10.
    Eisbruch A, Perez CA, Roessler EH, Lockett MA (1994) Adjuvant irradiation after prostatectomy for carcinoma of the prostate with positive surgical margins. Cancer 73: 384–387.PubMedCrossRefGoogle Scholar
  11. 11.
    Forman JD, Meetze K, Pontes E et al. (1997) Therapeutic irradiation for patients with an elevated post-prostatectomy prostate specific antigen level. J Urol 158:1436–1440.PubMedCrossRefGoogle Scholar
  12. 12.
    Formenti SC, Lieskovsky G, Simoneau AR et al. (1996) Impact of moderate dose of postoperative radiation on urinary continence and potency in patients with prostate cancer treated with nerve sparing prostatectomy. J Urol 155: 616–619.PubMedCrossRefGoogle Scholar
  13. 13.
    Freeman JA, Cook DW, Lieskovsky G et al. (1994) Adjuvant radiation, chemotherapy, and androgen deprivation therapy for pathologic stage Di adenocarcinoma of the prostate. Urology 44: 719–725.PubMedCrossRefGoogle Scholar
  14. 14.
    Fuks Z, Leibel SA, Wallner KE et al. (1991) The effect of local control on metastatic dissemination in carcinoma of the prostate; Longterm results in patients treated with 125 J implantation. Int J Radiat Oncol Biol Phys 21: 537–547.PubMedCrossRefGoogle Scholar
  15. 15.
    Kaplan ID, Bagshaw MA (1992) Serum prostate-specific antigen after post-prostatectomy radiotherapy. Urology 39: 401–406.PubMedCrossRefGoogle Scholar
  16. 16.
    Keisch ME, Perez CA, Grigsby PW, Bauer WC, Catalona W (1990) Preliminary report on 10 patients treated with radiotherapy after radical prostatectomy for isolated elevation of serum PSA-levels. Int J Radiat Oncol Biol Phys 19:1503–1506.PubMedCrossRefGoogle Scholar
  17. 17.
    Kuban DA, El-Mahdi AM, Schellhammer PF (1987) Effect on local tumor control on distant metastasis and survival in prostatic adenocarcinoma. Urology 30: 420–426.PubMedCrossRefGoogle Scholar
  18. 18.
    Lange PH, Lightner DJ, Medini E, Reddy PK, Vesella RL (1990) The effect of radiation therapy after radical prostatectomy in patients with elevated prostate specific antigen levels. J Urol 144: 927–932.PubMedGoogle Scholar
  19. 19.
    Lightner DJ, Lange PH, Reddy PK, Moore L (1990) Prostate specific antigen and local recurrence after radical prostatectomy. J Urol 144: 921–926.PubMedGoogle Scholar
  20. 20.
    Link P, Freiha FS, Stamey TA (1991) Adjuvant radiation therapy in patients with detectable prostate specific antigen following radical prostatectomy. J Urol 145: 532–534.PubMedGoogle Scholar
  21. 21.
    Meier R, Mark R, St. Royal L, Tran L, Colburn G, Parker R (1992) Postoperative radiation therapy after radical prostatectomy for prostate carcinoma. Cancer 70:1960–1966. PubMedCrossRefGoogle Scholar
  22. 22.
    Morgan WR, Bergstrahl EJ, Zincke H (1993) Long-term evaluation of radical prostatectomy as treatment for clinical stage C (T3) prostate cancer.Urology 41:116–120.CrossRefGoogle Scholar
  23. 23.
    Morris MM, Dallow KC, Zietman AL, Park J, Althausen A, Heney NM, Shipley WU (1997) Adjuvant and salvage irradiation following radical prostatectomy for prostate cancer. Int J Radiat Oncol Biol Phys 38: 731–736.PubMedCrossRefGoogle Scholar
  24. 24.
    Ohori M, Wheeler TM, Kattan MW, Goto Y, Scardino PT (1995) Prognostic significance of positive surgical margins in radical prostatectomy specimens. J Urol 154:1818–1824.PubMedCrossRefGoogle Scholar
  25. 25.
    Ouden D van den, Bentvelsen FM, Boeve ER, Schröder FH (1993) Positive margins after radical prostatectomy: correlation with local recurrence and distant progression. Br J Urol 72: 489–494.PubMedCrossRefGoogle Scholar
  26. 26.
    Partin AW, Pound CR, Clemens JQ, Epstein JI, Walsh PC (1993) Serum PSA after anatomic radical prostatectomy: the Johns Hopkins experience after 10 years. Urol Clin North Am 20: 713–725.PubMedGoogle Scholar
  27. 27.
    Partin AW, Pearson JD, Landis PK et al. (1994) Evaluation of serum prostate-specific antigen velocity after radical prostatectomy to distinguish local recurrence from distant metastases. Urology 43: 649–659.PubMedCrossRefGoogle Scholar
  28. 28.
    Perez CA, Eisbruch A (1993) Role of postradical prostatectomy irradiation in carcinoma of the prostate. Sem Radiooncol 3:198–209.Google Scholar
  29. 29.
    Petrovich Z, Lieskovsky G, Langholz B et al. (1998) Radical prostatectomy and postoperative irradiation in patients with pathological stage C (T3) carcinoma of the prostate. Int J Radiat Oncol Biol Phys 40:139–147.PubMedCrossRefGoogle Scholar
  30. 30.
    Schild SE, Wong WW, Grado GL et al. (1994) Radiotherapy for isolated increases in serum prostate-specific antigen levels after radical prostatectomy. Mayo Clin Proc 69: 613–619.PubMedGoogle Scholar
  31. 31.
    Schild SE, Wong WW, Grado GL et al. (1996) The results of radical retropubic prostatectomy and adjuvant therapy for pathological stage C prostate cancer. Int J Radiat Oncol Biol Phys 34: 535–541.PubMedCrossRefGoogle Scholar
  32. 32.
    Shevlin BE, Mittal BB, Brand WN, Shetty RM (1989) The role of adjuvant irradiation following primary prostatectomy, based on histopathologic extent of tumor. Int J Radiat Oncol Biol Phys 16: 1425–1430.PubMedCrossRefGoogle Scholar
  33. 33.
    Stein A, de Kernion JB, Drey F (1992) Adjuvant radiotherapy in patients post radical prostatectomy with tumor extending through capsule or positive seminal vesicles. Urology 39: 59–62.PubMedCrossRefGoogle Scholar
  34. 34.
    Syndicus I, Pickles T, Kostashuk E, Sullivan LD (1996) Postoperative radiotherapy for stage pT3 carcinoma of the prostate: improved local control. J Urol 155:1983–1986.CrossRefGoogle Scholar
  35. 35.
    Wiegel T, Bressel M (1994) Influence of the extent of nodal involvement on the outcome in stage Di prostate cancer. Radiat Oncol Invest 2:144–151.CrossRefGoogle Scholar
  36. 36.
    Wiegel T, Bressel M (1995) Stage Di prostate cancer — is radiotherapy and early hormonal therapy equivalent to radical prostatectomy, radiotherapy, and early hormonal treatment? Int J Radiat Oncol Biol Phys 32: 896–897.PubMedGoogle Scholar
  37. 37.
    Wiegel T, Bressel M (1995) Adjuvant radiotherapy following radical prostatectomy — results of 56 patients. Eur J Cancer 31 A: 5–11.CrossRefGoogle Scholar
  38. 38.
    Wiegel T, Bressel M, Arps H, Hübener KH (1992) Radiotherapy of local recurrence following radical prostatectomy. Strahlenther Onkol 168: 333–336.PubMedGoogle Scholar
  39. 39.
    Wiegel T, Schmidt R, Krüll A et al. (1993) Advantage of three-dimensional treatment planning for localized radiotherapy of early stage prostate cancer. Strahlenther Onkol 168: 692–697.Google Scholar
  40. 40.
    Wiegel T, Bressel M, Schmidt R (1994) Stage Di prostatic cancer — equivalent results with radiotherapy and hormonal therapy vs. radical prostatectomy, radiotherapy and hormonal therapy (?). Onkologie 17: 586–593.CrossRefGoogle Scholar
  41. 41.
    Wiegel T, Hinkelbein W, Steiner U, Miller K (1997) Postoperative radiotherapy for stage pT3 carcinoma of the prostate: improved local control. Letter to the editor. J Urol 159: 965–966.Google Scholar
  42. 42.
    Wiegel T, Steiner U, Hinkelbein W (1997) Adjuvante Strahlentherapie nach radikaler Prostatektomie — Indikationen, Ergebnisse, Nebenwirkungen. Strahlenther Onkol 173: 309–315.PubMedCrossRefGoogle Scholar
  43. 43.
    Wu JJ, King SC, Montana GS, McKinstry CA, Anscher MS (1995) The efficacy of postprostatectomy radiotherapy in patients with an isolated elevation of serum prostate-specific antigen. Int J Radiat Oncol Biol Phys 32: 317–323.PubMedCrossRefGoogle Scholar
  44. 44.
    Zietman AL, Edelstein RA, Coen JJ, Babayan RK, Krane RJ (1994). Radical prostatectomy for adenocarcinoma of the prostate: the influence of preoperative and pathologic findings on biochemical disease-free outcome. Urology 43: 828–833.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1999

Authors and Affiliations

  • T. Wiegel
  • W. Hinkelbein

There are no affiliations available

Personalised recommendations